Evidence map›Paper›PMID 39819887›Full record

ArticleNPJ breast cancer2025

Racial discrimination among women seeking breast cancer care.

Lauren J Oshry, Ruth I Lederman, Haley Gagnon, Tsion Fikre, Daniel A Gundersen, Anna C Revette, Ashley Odai-Afotey, Olga Kantor, Dawn L Hershman, Katherine D Crew and 3 more

Abstract read
In one paragraph

Article in NPJ breast cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Lauren J OshrySection of Hematology and Medical Oncology, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA.
Ruth I LedermanSurvey and Qualitative Methods Core, Dana-Farber Cancer Institute, Boston, MA, USA.
Haley GagnonDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Tsion FikreSection of Hematology and Medical Oncology, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA.
Daniel A GundersenSurvey and Qualitative Methods Core, Dana-Farber Cancer Institute, Boston, MA, USA.
Anna C RevetteSurvey and Qualitative Methods Core, Dana-Farber Cancer Institute, Boston, MA, USA.
Ashley Odai-AfoteyDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Olga KantorDivision of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Dawn L HershmanDepartment of Medicine and Epidemiology, Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, New York, NY, USA.
Katherine D CrewDepartment of Medicine and Epidemiology, Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-9637-2962
Nancy L KeatingDivision of General Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Rachel A FreedmanDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Naomi Y KoSection of Hematology and Medical Oncology, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA. naomi.ko@bmc.org.ORCID http://orcid.org/0000-0001-9689-9601

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
American Cancer Society (American Cancer Society, Inc.) MRSG-14-240-01-CPPB to RAFNCI NIH HHS P30 CA013696Susan G. Komen (Susan G. Komen Breast Cancer Foundation) CCRCR18552788 to RAF
6 · The paper itself

Abstract

Discrimination can contribute to worse health outcomes, but its prevalence in breast cancer is not well studied. We aimed to understand how women with stage I-III breast cancer faced discrimination in health care and everyday settings through the Everyday Discrimination Scale, cross-sectional survey. 296 women, 178 (60%) Non-Hispanic White (NHW), 76 (26%) Non-Hispanic Black (NHB), and 42 (14%) Hispanic participated. NHB women reported significantly more discrimination in everyday life compared to NHW women (score 20.1 vs 16.1, p < 0.001) and Hispanic women (score 20.1 vs 16.0, p < 0.001). In the health care setting, NHB had statistically more frequent reports of being ignored (23.7% vs. 5.6%), treated with less respect (21.1% vs. 7.3%), and treated with less courtesy (18.7% vs. 6.2%; all P = < 0.001) when compared to NHW women. NHB women experience a higher degree of discrimination both inside and outside of health care. Further research to understand discrimination on breast cancer outcomes is warranted.

Identifiers

PMID39819887
PMCPMC11739410

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.